Open Access

Poster Session 1 - Valvular Heart Disease – Treatment

Event: Heart Failure 2018 & World Congress on Acute Heart Failure
Topic: Other
Session type: Poster Session
Date: 26 May 2018

Session

7 presentations in this session

The importance of heart failure with reduced ejection fraction in a cohort with infective endocarditis: a single-centre experience

Speaker: Doctor C. Primus (London, GB)
Thumbnail

Relationship among gradient and systolic function: prognosis impact after TAVR

Speaker: Doctor P. Meras Colunga (Madrid, ES)
Thumbnail

Do the patients with coronary artery disease have the same benefits from transcatheter aortic valve implantation?

Speaker: Doctor P. Araujo (Porto, PT)
Thumbnail

Anticoagulant strategy for prosthetic valve in patients with endocarditis does not influence anemia, preexistent heart failure and mortality

Speaker: Doctor M. Baluta (Bucharest, RO)
Thumbnail

Congestive heart failure in patients with post rheumatic valvulopathies: occurrence and management in a tertiairy subsaharan centre

Speaker: Doctor J. Tantchou (Kumbo, CM)
Thumbnail

Transcatheter aortic valve implantation: a real-life experience

Speaker: Miss M. Braga (Porto, PT)
Thumbnail

Evolution of Functional Mitral Regurgitation

Speaker: Doctor P. Bartko (Vienna, AT)
Thumbnail

7 speakers from this session

Doctor Christopher Peter Primus

St Bartholomew's Hospital and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Pablo Meras Colunga

University Hospital La Paz, Madrid (Spain)
1 presentation
0 follower

Doctor Paulo Maia Araujo

Sao Joao Hospital, Porto (Portugal)
4 presentations
0 follower

Doctor Monica Mariana Baluta

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)
0 follower

Doctor Jacques Cabral Tantchou

St. Elizabeth Catholic General Hospital, Kumbo (Cameroon)
0 follower

Miss Marta Braga

Sao Joao Hospital, Porto (Portugal)
2 presentations
0 follower

Doctor Philipp Emanuel Bartko

Medical University of Vienna, Department of Internal Medicine II, Division of Cardiology, Vienna (Austria)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk